Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03639090 · ClinicalTrials.gov registry record
Mass Spectrometry in Single Bladder Cancer Cells
A clinical trial, sponsored by University of Oklahoma.
- Completed
- Registry status
- 2
- Enrollment target
NCT03639090 is a clinical trial that has completed, run by University of Oklahoma. The registered enrollment target is 2 participants.
The verdict
NCT03639090 has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The study is a pilot study in the feasibility of a diagnostic technique. There is no current data on detection of cisplatin in cancer cells derived from human urine. This study will generate preliminary data so that future studies may be done with more definitive end points in mind.
Interventions
- DIAGNOSTIC_TEST mass spectrometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2020-10-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03639090
The ClinicalTrials.gov registry entry for NCT03639090 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mass spectrometry is the first listed.
NCT03639090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03639090 about?
NCT03639090 is a clinical study titled "Mass Spectrometry in Single Bladder Cancer Cells". The study is a pilot study in the feasibility of a diagnostic technique. There is no current data on detection of cisplatin in cancer cells derived from human urine. This study will generate preliminary data so that future studies may be done with more definitive end points in mind.
What is the current status of trial NCT03639090?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2017-07-01. Estimated completion is 2020-10-08.
What interventions are being tested in trial NCT03639090?
The interventions under investigation include: mass spectrometry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03639090?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.